Gene transfer into neural cells In vitro using adenoviral vectors

Current Protocols in Neuroscience

Volumn , Issue SUPPL. 45, 2008, Pages

  Southgate, Thomas ^a   Kroeger, Kurt M ^a   Liu, Chunyan ^a   Lowenstein, Pedro R ^a   Castro, Maria G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenovirus vectors; Fluorescence activated cell sorting (FACS); Gene transfer neurons; Glial cells Immunocytochemistry; Purification

Indexed keywords

ADENOVIRUS VECTOR; LIPOPOLYSACCHARIDE;

ADENOVIRUS; ANIMAL TISSUE; ASSAY; CENTRAL NERVOUS SYSTEM; CLONE; ENZYMATIC ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE AMPLIFICATION; GENE EXPRESSION; GENE INSERTION; GENE TRANSFER; GENETIC TRANSDUCTION; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; METHODOLOGY; NERVE CELL; NERVE CELL CULTURE; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW; RODENT; TRANSGENE; VIRAL CONTAMINATION; VIRUS TITRATION; ANIMAL; ARTICLE; CELL CULTURE; CYTOLOGY; GENE VECTOR; GENETICS; PHYSIOLOGY; CULTURE TECHNIQUE; GLIA; METABOLISM; MOUSE; RAT; STANDARD;

ADENOVIRIDAE; ANIMALS; CELLS, CULTURED; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; NEURONS; CELL CULTURE TECHNIQUES; GENE EXPRESSION; MICE; NEUROGLIA; RATS; TRANSGENES;

EID: 45549099627     PISSN: 19348584     EISSN: 19348576     Source Type: Journal    
DOI: 10.1002/0471142301.ns0423s45     Document Type: Review

References (46)

1. Barcia, C., Thomas, C.E., Curtin, J.F., King, G.D., Wawrowsky, K., Candolfi, M., Xiong, W.D., Liu, C., Kroeger, K., Boyer, O., Kupiec- Weglinski, J., Klatzmann, D., Castro, M.G., and Löwenstein, P.R. 2006. In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brain. J. Exp. Med. 203:2095-107.
2. Bett, A.J., Haddara, W., Prevec, L., and Graham, F.L. 1994. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. U.S.A. 91:8803-8806.
3. Berkner, K.L. and Sharp, P.A., 1983. Generation of adenovirus by cotransfection of plasmids. Nucleic Acids Res. 11:6003-6020.
4. Berkner, K.L. and Sharp, P.A., 1984. Expression of dihydrofolate reductase, and of the adjacent E1b region, in an Ad5-dihydrofolate reductase recombinant virus. Nucleic Acids Res. 12:1925-1941.
5. Burlingham, B.T., Brown, D.T., and Doerfler, W. 1974. Incomplete particles of adenovirus. I. Characteristics of the DNA associated with incomplete adenovirions of types 2 and 12. Virology 60:419-430.
6. Candolfi, M., Curtin, J.F., Xiong, W.D., Kroeger, K.M., Liu, C., Rentsendorj, A., Agadjanian, H., Medina-Kauwe, L., Palmer, D., Ng, P., Löwenstein, P.R., and Castro, M.G. 2006. Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells. Mol. Ther. 14:371-381.
7. Candolfi, M., Pluhar, G.E., Kroeger, K., Puntel, M., Curtin, J., Barcia, C., Muhammad, A.K, Xiong, W., Liu, C., Mondkar, S., Kuoy, W., Kang, T., McNeil, E.A., Freese, A.B., Ohlfest, J.R., Moore, P., Palmer, D., Ng, P., Young, J.D., Lowenstein, P.R., and Castro, M.G. 2007. Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro. Neuro. Oncol. 9:245-258.
8. Cartmell, T., Southgate, T.D., Rees, G.S., Castro, M.G., Lowenstein, P.R., and Luheshi, G.N. 1999. Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors in the brain. J. Neurosci. 19:1517-1523.
9. Chartier, C., Degryse, E., Gantzer,M., Dieterle, A., Pavirani, A., and Mehtali, M. 1996. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70:4805-4810.
10. Cowsill, C., Southgate, T.D.,Morrissey G., Dewey, R.A., Morelli, A.E., Maleniak, T.C., Forrest, Z., Klatzmann, D., Wilkinson, G.W.G., Lowenstein, P.R., and Castro, M.G. 2000. Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: Reduced cytotoxicity of a truncated HSV1-TK. Gene Ther. 7:679-685.
11. Dewey, R.A., Morrissey, G., Cowsill, C.M., Stone, D.,Bolognani, F., Dodd, N.J.F., Southgate, T.D., Klatzmann, D., Lassmann, H.,Castro, M.G., and Löwenstein. P.R. 1999. Chronic brain inflammation and persistent HSV1-TK expression in survivors of syngeneic glioma treated by adenovusmediated gene therapy: Implications for clinical trials. Nat. Med. 5:1256-1263.
12. Dion, L.D., Fang, J., and Garver, R.I. 1996. Supernatant rescue assay vs. polymerase chain reaction for detection of wild type adenoviruscontaining recombinant adenovirus stocks. J. Virol. Methods 56:99-107.
13. Easton, R.M., Johnson, E.M., and Creedon, D.J. 1998. Analysis of events leading to neuronal death after infection with E1-deficient adenovirus vectors. Mol. Cell. Neurosci. 11:334-347.
14. Fallaux, F.J., Kranenburg, O., Cramer, S.J., Houweling, A., van Ormondt, H., Hoeben, R.C., and van der Eb, A.J. 1996. Characterization of 911: A new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 7:215-222.
15. Fallaux, F.J., Bout, A., van der Velde, I., van den Wollenberg, D.J.M., Hehir, K.M., Keegan, J., Auger, C., Cramer, S.J., van Ormondt, H., van der Eb, A.J.,Valerio,D., andHoeben, R.C. 1998. New helper cells and matched early region 1- deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. 9:1909-1917.
16. Gluzman, Y. and Van Doren, K. 1983. Palindromic adenovirus type 5-SV40 hybrid. J. Virol. 45:91-103.
17. Gossen, M. and Bujard, H., 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 89:5547-5551.
18. Graham, F.L., Smiley, J., Russell,W.C., and Nairu, R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 68:937-940.
19. Hehir, K.M., Armenatano, D., Cardoza, L.M., Choquette, T.L., Berthelette, P.B., White, G.A., Couture, L.A., Everton, M.B., Keegan, J., Martin, J.M., Pratt, D.A., Smith, M.P., Smith, A.E., and Wadsworth, S.C. 1996. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J. Virol. 70:8459-8467.
20. Imler, J.-L., Chartier, C., Dreyer, D., Sainte-Marie, M., Faure, T., Pavirani, A., and Mehtali, M. 1996. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors. Gene Ther. 3:75-84.
21. Ketner, G., Spencer, F., Tugendrreich, S., Connely, C., and Hieter, P. 1994. Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone. Proc. Natl. Acad. Sci. U.S.A. 91:6186-6190.
22. Krougliak, V. and Graham, F.L. 1995. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Hum. Gene Ther. 6:1575-1586.
23. Lavoie, J.N., Champagne, C., Gingras, M.C., and Robert, A. 2000. Adenovirus E4 open reading frame 4-induced apoptosis involves dysregulation of Src family kinases. J. Cell Biol. 150:1037-1056.
24. Liebermann, H. and Mentel, R. 1994. Quantification of adenovirus particles. J. Virol. Methods 50:281-291.
25. Lochmuller, H., Jani, A., Huard, J., Prescot, S., Simoneau, M., Massie, B., Karpati, G, and Acsadi, G. 1994. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. Hum. Gene Ther. 5:1485-1491.
26. Louis, N., Evelegh, C., and Graham, F.L. 1997. Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line. Virology 233:423- 429.
27. Löwenstein, P.R., Shering, A., Bain, D., Castro, M.G., and Wilkinson, G.W.G. 1996. The use of adenovirus vectors to transfer genes to identified target brain cells in vitro. In Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders. (P.R.Löwenstein and L.W. Enquist, eds.) pp. 93-114. John Wiley & Sons, Chichester, U.K.
28. Mahr, A.J. and Gooding, L.R. 1999. Immune evasion by adenoviruses. Immunol. Rev. 168:121-130.
29. McVey, D., Zuber, M., Ettyreddy, D., Brough, D.E., and Kovesdi, I. 2002. Rapid construction of adenoviral vectors by lambda phage genetics. J. Virol. 76:3670-3677.
30. Morelli, A.E., Larregina, A.T., Smith-Arica, J., Dewey, R.A., Southgate, T.D., Ambar, B., Fontana, A., Castro, M.G., and Löwenstein, P.R. 1999. Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity. J. Gen. Virol. 80:571-583.
31. Ng, P. and Graham F.L. 2002. Construction of first generation adenoviral vectors. Methods Mol. Med. 69:389-414.
32. Noble, M. and Mayer-Proschel, M. 1998. Culture of astrocytes, oligodendrocytes and O-2A progenitor cells. In Culturing Nerve Cells: Cellular and Molecular Neuroscience. (G. Banker and K. Goslin, eds.) pp. 499-543. MIT Press, Cambridge, Mass.
33. Palmer, D.J. and Ng, P. 2003. Improved system for helper-dependent adenoviral vector production. Mol. Ther. 8:846-852.
34. Parks, R.J., Chen, L., Anton, M., Sankar, U., Rudnicki, M.A., and Graham, F.L. 1996. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. U.S.A. 93:13565-13570.
35. Paxinos, G., Ashwell, K.W.S., and Tork, I. 1994. Atlas of the Developing Rat Nervous System. Academic Press, San Diego.
36. Puntel, M., Curtin, J.F, Zirger, J.M., Muhammad, A.K., Xiong,W., Liu, C., Hu, J., Kroeger, K.M., Czer, P., Sciascia, S., Mondkar, S., Löwenstein, P.R., and Castro, M.G. 2006. Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reaction. Hum. Gene Ther. 17:531-544.
37. Revah, F., Horellou, P., Vigne, E., Le Gal La Salle, G., Robert, J.J., Perricaudet, M., and Mallet, J. 1996. Gene transfer into the central and peripheral nervous system using adenoviral vectors. In Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders. (P.R. Löwenstein and L.W. Enquist, eds.) pp. 81-92. JohnWiley & Sons, Chichester, U.K.
38. Shering, A.F., Bain, D., Stewart, K., Epstein, A.L., Castro, M.G., Wilkinson, G.W.G., and Löwenstein, P.R. 1997. Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors. J. Gen. Virol. 78:445-459.
39. Smith-Arica, J.R., Morelli, A.E., Larregina, A.T., Smith, J., Löwenstein, P.R., and Castro, M.G. 2000. Cell-type-specific and regulatable transgenesis in the adult brain: Adenovirus-encoded combined transcriptional targeting and inducible transgene expression. Mol. Ther. 2:579-587.
40. Spessot, R., Inchley,K., Hupel, T.M., and Bacchetti, S. 1989. Cloning of the herpes-simplex virus ICP4 gene in an adenovirus vector-effects on adenovirus gene-expression and replication. Virology 168:378-387.
41. Thomas, C.E., Birkett, D., Anozie, I., Castro,M.G., and Lowenstein, P.R. 2001. Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain. Mol. Ther. 3:36-46.
42. Tollefson, A.E., Hermiston, T.W., and Wold, W.S.M., 1999. Preparation and titration of CsClbanded adenovirus stock. In Adenovirus Methods and Protocols (W.S.M. Wold, ed.) pp. 1-9. Humana Press, Totowa, N.J.
43. Wilkinson, G.W.G. and Akrigg, A. 1992. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acid Res. 20:2233-2239.
44. Windeatt, S., Southgate, T.D., Dewey, R.A., Bolognani, F., Perone, M.J., Larregina, A.T., Maleniak, T.C., Morris, I.D., Goya, R.G., Klatzmann, D., Löwenstein, P.R., and Castro, M.G., 2000. Adenovirus-mediated Herpes simplex virus type-1 thymidine kinase (HSV1-TK) gene therapy suppresses oestrogen induced pituitary prolactinomas. J. Clin. Endo. Metab. 85:1296-1305.
45. Xiong, W., Goverdhana, S., Sciascia, S.A., Candolfi, M., Zirger, J.M., Barcia, C., Curtin, J.F., King, G.D., Jaita, G., Liu, C., Kroeger, K., Agadjanian, H., Medina-Kauwe, L., Palmer, D., Ng, P., Löwenstein, P.R., and Castro,M.G. 2006. Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses. J. Virol. 80:27-37.
46. Zirger, J.M., Barcia, C., Liu, C., Puntel, M., Mitchell, N., Campbell, I., Castro, M., and Lowenstein, P.R. 2006. Rapid upregulation of interferon-regulated and chemokine mRNAs upon injection of 108 international units, but not lower doses, of adenoviral vectors into the brain. J. Virol. 80:5655-5659.